Coya Therapeutics, Inc.COYANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+50.2%
5Y CAGR+113.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+50.2%/yr
Annual compound
5Y CAGR
+113.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
44.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $16.73M | +40.7% |
| 2024 | $11.89M | +96.7% |
| 2023 | $6.04M | +22.4% |
| 2022 | $4.94M | +94.2% |
| 2021 | $2.54M | +580.7% |
| 2020 | $373454.00 | - |